Rhythm Pharmaceuticals, Inc. (RYTM)
96.61
+4.30
(+4.66%)
USD |
NASDAQ |
May 06, 16:00
96.69
+0.08
(+0.08%)
After-Hours: 07:06
Rhythm Pharmaceuticals Cash from Investing (Quarterly) : 57.05M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 16.00M |
| Eli Lilly & Co. | -3.916B |
| Merck & Co., Inc. | -10.21B |
| Sarepta Therapeutics, Inc. | 96.21M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.18M |
| Cash from Financing (Quarterly) | -5.40M |
| Free Cash Flow | -160.46M |
| Free Cash Flow Per Share (Quarterly) | -0.65 |
| Free Cash Flow to Equity (Quarterly) | -28.07M |
| Free Cash Flow to Firm (Quarterly) | -39.56M |
| Free Cash Flow Yield | -2.51% |